Ginsenosides or panaxosides are a class of natural product steroid glycosides and triterpene saponins. Compounds in this family are found almost exclusively in the plant genus Panax (ginseng), which has a long history of use in traditional medicine that has led to the study of pharmacological effects of ginseng compounds. As a class, ginsenosides exhibit a large variety of subtle and difficult-to-characterize biological effects when studied in isolation.
Ginsenosides can be isolated from various parts of the plant, though typically from the roots, and can be purified by column chromatography. The chemical profiles of Panax species are distinct; although Asian ginseng, Panax ginseng, has been most widely studied due to its use in traditional Chinese medicine, there are ginsenosides unique to American ginseng (Panax quinquefolius) and Japanese ginseng (Panax japonicus). Ginsenoside content also varies significantly due to environmental effects.
Ginsenosides are named according to their retention factor value in thin layer chromatography (TLC). They can be broadly divided into two groups based on the carbon skeletons of their aglycones: the four-ring dammarane family, which contains the majority of known ginsenosides, and the oleanane family. The dammaranes can be further subdivided into two main groups, the protopanaxadiols and protopanaxatriols, with other smaller groups such as the ocotillol-type pseudoginsenoside F11 and its derivatives.
Most known ginsenosides are classified as members of the dammarane family. The structure of these dammarane ginsenosides consists of a 4-ring, steroid-like structure. To each ginsenoside is bound at least 2 or 3 hydroxyl groups at the carbon-3 and -20 positions or the carbon-3, -6, and -20 positions respectively. In protopanaxadiols, sugar groups attach to the 3-position of the carbon skeleton, while in comparison sugar groups attach to the carbon-6 position in protopanaxatriols. Well known protopanaxadiols include Rb1, Rb2, Rg3, Rh2, and Rh3. Well known protopanaxatriols include Rg1, Rg2, and Rh1.
The biosynthetic pathway of ginsenosides is not entirely characterized, though as steroids they derive from pathways that lead to the synthesis of isoprene units. A proposed pathway converts squalene to 2,3-oxidosqualene via the action of squalene epoxidase, at which point dammaranes can be synthesized through dammarenediol synthase, oleananes through beta-amyrin synthase, and another class of molecules, the phytosterols, through cycloartenol synthase.
In the proposed pathway, squalene is synthesized from the assembly of two farnesyl diphosphate (FPP) molecules. Each molecule of FPP is in turn the product of two molecules of dimethylallyl diphosphate and two molecules of isopentenyl diphosphate (IPP). IPP is produced by the mevalonic pathway in the cytosol of a ginseng plant cell and by the methylerythritol phosphate pathway in the plant's plastid.
Ginsenosides likely serve as mechanisms for plant defense. Ginsenosides have been found to have both antimicrobial and antifungal properties. Ginsenoside molecules are naturally bitter-tasting and discourage insects and other animals from consuming the plant.
Ginseng is generally consumed orally as a dietary supplement, and thus its component ginsenosides may be metabolized by gut flora. For example, ginsenosides Rb1 and Rb2 are converted to 20-b-O-glucopyranosyl-20(S)-protopanaxadiol or 20(S)-protopanaxadiol by human gut bacteria. This process is known to vary significantly between individuals. In some cases the metabolites of ginsenosides may be the biologically active compounds.
Most studies of the biological effects of ginsenosides have been in cell culture or animal models and thus their relevance to human biology is unknown. Effects on the cardiovascular system, the central nervous system, the immune system have been reported, primarily in rodents. Antiproliferative effects have also been described.
Many studies suggest that ginsenosides have antioxidant properties. Ginsenosides have been observed to increase internal antioxidant enzymes and act as a free-radical scavenger. Ginsenosides Rg3 and Rh2 have been observed in cell models as having an inhibitory effect on the cell growth of various cancer cells while studies in animal models have suggested that ginsenosides have neuroprotective properties and could be useful in treating neurodegenerative disease such as Alzheimer's and Parkinson's diseases.
Two broad mechanisms of action have been suggested for ginsenoside activity, based on their similarity to steroid hormones. They are amphiphilic and may interact with and change the properties of cell membranes. Some ginsenosides have also been shown to be partial agonists of steroid hormone receptors. It is not known how these mechanisms yield the reported biological effects of ginsenosides. The molecules as a class have low bioavailability due to both metabolism and poor intestinal absorption.
- Attele, AS; Wu, JA; Yuan, CS (1 December 1999). "Ginseng pharmacology: multiple constituents and multiple actions.". Biochemical Pharmacology. 58 (11): 1685–93. doi:10.1016/s0006-2952(99)00212-9. PMID 10571242.
- Fuzzati, N (5 December 2004). "Analysis methods of ginsenosides.". Journal of Chromatography B. 812 (1-2): 119–33. doi:10.1016/j.jchromb.2004.07.039. PMID 15556492.
- Qi, LW; Wang, CZ; Yuan, CS (June 2011). "Ginsenosides from American ginseng: chemical and pharmacological diversity.". Phytochemistry. 72 (8): 689–99. doi:10.1016/j.phytochem.2011.02.012. PMC 3103855. PMID 21396670.
- Liang, Y; Zhao, S (July 2008). "Progress in understanding of ginsenoside biosynthesis.". Plant biology (Stuttgart, Germany). 10 (4): 415–21. doi:10.1111/j.1438-8677.2008.00064.x. PMID 18557901.
- Lü, J.-M.; Yao, Q.; Chen, C. (2009). "Ginseng Compounds: An Update on Their Molecular Mechanisms and Medical Applications". Current Vascular Pharmacology. 7 (3): 293–302. doi:10.2174/157016109788340767. PMC 2928028. PMID 19601854.
- Shibata, S (Dec 2001). "Chemistry and Cancer Preventing Activities of Ginseng Saponins and Some Related Triterpenoid Compounds". J Korean Med Sci. 16 (Suppl): S28–S37. doi:10.3346/jkms.2001.16.S.S28.
- Kim, Yu-Jin; Zhang, Dabing; Yang, Deok-Chun (2015-11-01). "Biosynthesis and biotechnological production of ginsenosides". Biotechnology Advances. 33 (6, Part 1): 717–735. doi:10.1016/j.biotechadv.2015.03.001.
- Leung, KW; Wong, AS (11 June 2010). "Pharmacology of ginsenosides: a literature review.". Chinese medicine. 5: 20. doi:10.1186/1749-8546-5-20. PMID 20537195.
- Bae, Eun-Ah; Han, Myung Joo; Choo, Min-Kyung; Park, Sun-Young; Kim, Dong-Hyun (2002-01-01). "Metabolism of 20(S)- and 20(R)-Ginsenoside Rg3 by Human Intestinal Bacteria and Its Relation to in Vitro Biological Activities". Biological and Pharmaceutical Bulletin. 25 (1): 58–63. doi:10.1248/bpb.25.58.
- Christensen, LP (2009). "Ginsenosides chemistry, biosynthesis, analysis, and potential health effects.". Advances in Food and Nutrition Research. 55: 1–99. doi:10.1016/S1043-4526(08)00401-4. PMID 18772102.